The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: a comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP).

Hainsworth JD, Jones HW, Burnett LS, Johnson DH, Greco FA
Am J Clin Oncol. 1990 13 (5): 410-5

PMID: 2121019 · DOI:10.1097/00000421-199010000-00009

MeSH Terms (17)

Adult Aged Altretamine Antineoplastic Combined Chemotherapy Protocols Chi-Square Distribution Cisplatin Cyclophosphamide Doxorubicin Drug Evaluation Female Humans Middle Aged Ovarian Neoplasms Regression Analysis Remission Induction Retrospective Studies Survival Rate

Connections (1)

This publication is referenced by other Labnodes entities:

Links